Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001907267 | SCV002118756 | likely benign | Alagille syndrome due to a JAG1 point mutation | 2022-08-31 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003355575 | SCV004070688 | uncertain significance | Cardiovascular phenotype | 2024-05-06 | criteria provided, single submitter | clinical testing | The c.3083T>G (p.I1028S) alteration is located in exon 25 (coding exon 25) of the JAG1 gene. This alteration results from a T to G substitution at nucleotide position 3083, causing the isoleucine (I) at amino acid position 1028 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |